Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F14%3A10292968" target="_blank" >RIV/00064203:_____/14:10292968 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11130/14:10292968

Result on the web

<a href="http://dx.doi.org/10.3324/haematol.2013.099747" target="_blank" >http://dx.doi.org/10.3324/haematol.2013.099747</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3324/haematol.2013.099747" target="_blank" >10.3324/haematol.2013.099747</a>

Result language

angličtina

Original language name

Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel

Original language description

Thalassemia major and sickle cell disease are the two most widely disseminated hereditary hemoglobinopathies in the world. The outlook for affected individuals has improved in recent years due to advances in medical management in the prevention and treatment of complications. However, hematopoietic stem cell transplantation is still the only available curative option. The use of hematopoietic stem cell transplantation has been increasing, and outcomes today have substantially improved compared with thepast three decades. Current experience world-wide is that more than 90% of patients now survive hematopoietic stem cell transplantation and disease-free survival is around 80%. However, only a few controlled trials have been reported, and decisions on patient selection for hematopoietic stem cell transplantation and transplant management remain principally dependent on data from retrospective analyses and on the clinical experience of the transplant centers. This consensus document from

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2014

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Haematologica

ISSN

0390-6078

e-ISSN

—

Volume of the periodical

99

Issue of the periodical within the volume

5

Country of publishing house

IT - ITALY

Number of pages

10

Pages from-to

811-820

UT code for WoS article

000336257500008

EID of the result in the Scopus database

—